Wheadon David E.
SEC-identified person · CIK 1789507 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Sotera Health Co SHC | Director | filed 2021 - 2026 |
| Indivior Pharmaceuticals, Inc. INDV | Director | filed 2026 - 2026 |
| Seaport Therapeutics, Inc. SPTX | Director | filed 2026 - 2026 |
| Vaxart, Inc. VXRT | Director | filed 2021 - 2025 |
| Karuna Therapeutics, Inc. KRTX | Director | filed 2020 - 2024 |
| Chemocentryx, Inc. CCXI | Director | filed 2022 - 2022 |
| Assertio Holdings, Inc. ASRT | Director | filed 2020 - 2020 |
| Depomed INC DEPO | Director | filed 2019 - 2019 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.